Potency evaluation of erythropoietin products: current status
INTRODUCTION. Given the widespread clinical use of recombinant human erythropoietin (rhEPO) products from different manufacturers, potency assays should ensure that patients receive comparable doses of rhEPO across medicinal products. The harmonisation of approaches to potency testing requires the u...
Saved in:
| Main Authors: | L. A. Gaiderova, N. A. Alpatova, S. L. Lysikova, A. M. Guskov, O. V. Golovinskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-12-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/614 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant erythropoietin in the treatment of anemia in cancer patients
by: S. V. Vorobiova, et al.
Published: (2022-11-01) -
THE STUDY OF RENOPROTECTIVE PROPERTIES OF ERYTROPOETIN DERIVATIVES ON THE KIDNEY ISCHEMIA-REPERFUSION MODEL
by: V. V. Elagin, et al.
Published: (2018-12-01) -
Certification of a pharmacopoeial reference standard for potency testing of recombinant interferon α-2b
by: L. A. Gaiderova, et al.
Published: (2024-03-01) -
Enzyme-linked immunosorbent assay to determine the potency of a rotavirus vaccine based on virus-like particles: analytical procedure development and validation
by: I. E. Filatov, et al.
Published: (2024-12-01) -
The development of a method for determining the biological activity of erythropoietin preparations in vitro
by: N. A. Gavrilova, et al.
Published: (2018-02-01)